Moleculin Biotech Inc.

MBRX | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.52

-$0.25 (-32.74%)

At close: Sep 21, 2026, 4:00 PM ET

$0.53

+$0.01 (+1.25%)

Pre-market: Sep 22, 2026, 6:28 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Cash & Equivalents	8.88M	4.28M	23.55M	43.15M	70.9M	15.17M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	129K
Other Long-Term Assets	978K	n/a	n/a	n/a	n/a	n/a
Receivables	7K	n/a	n/a	n/a	45K	1K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	278K	351K	644K	823K	486K	1.45M
Total Current Assets	9.69M	5.19M	26.27M	45.6M	72.5M	17.2M
Property-Plant & Equipment	314K	583K	796K	678K	445K	685K
Goodwill & Intangibles	11.15M	11.15M	11.15M	11.15M	11.15M	11.15M
Total Long-Term Assets	12.44M	11.73M	11.94M	11.83M	11.59M	11.96M
Total Assets	22.13M	16.93M	38.22M	57.42M	84.09M	29.16M
Account Payables	3.51M	2.03M	2.5M	2.1M	1.36M	1.13M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	137K	n/a	n/a	n/a	96K	118K
Other Current Liabilities	1.39M	n/a	n/a	n/a	1.56M	1.25M
Total Current Liabilities	6.85M	5.36M	6.82M	4.82M	3.62M	2.92M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	44K	5.23M	4.86M	77K	1.41M	8.19M
Total Long-Term Liabilities	266K	5.59M	5.33M	412K	1.48M	8.35M
Total Liabilities	7.12M	10.95M	12.14M	5.23M	5.1M	11.27M
Total Debt	359K	478K	574K	451K	159K	277K
Book Value	15.01M	5.98M	26.07M	52.19M	78.99M	17.89M
Book Value Per Share	12.67	43.41	329.94	684.22	1.1K	681.36
Common Stock	3K	3K	33K	29K	29K	69K
Retained Earnings	-206M	-153.37M	-131.6M	-101.84M	-72.81M	-56.92M
Comprehensive Income	10K	-41K	-9K	12K	41K	65K
Shareholders Equity	15.01M	5.98M	26.07M	52.19M	78.99M	17.89M
Total Investments	n/a	n/a	n/a	n/a	n/a	129K